Brief: Cytodyn Inc Says Agreement To Partner With Albert Einstein Israelite Hospital In São Paulo, Brazil For Two COVID-19 Trials
05/05/2021 08:39
May 5 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN INC - AGREEMENT TO PARTNER WITH ALBERT EINSTEIN
ISRAELITE HOSPITAL IN SÃO PAULO, BRAZIL FOR TWO COVID-19 TRIALS
* CYTODYN INC- THESE TWO PHASE 3 TRIALS WILL BE CONDUCTED IN
UP TO
45 CLINICAL SITES
* CYTODYN INC - INTERIM ANALYSIS FOR CRITICALLY ILL
POPULATION TO
BE CONDUCTED WHEN ENROLLMENT REACHES ABOUT 120 PATIENTS OR 40%
OF ABOUT 300 PATIENTS
* CYTODYN INC - EXPECT AN INTERIM ANALYSIS WILL BE CONDUCTED
IN
OCTOBER-NOVEMBER OF THIS YEAR
Source text for Eikon: ID:nGNX9kWXJ8
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer